Pfizer’s Hospira buyout approved in Australia and Canada

18-08-2015

Pfizer’s Hospira buyout approved in Australia and Canada

Aleksandar Mijatovic / Shutterstock.com

Pfizer’s $17 billion buyout of Hospira has been approved in Canada and Australia after the countries’ competition bureaus approved the deal.


Pfizer, Hospira, Australian Competition and Consumer Commission, Canada’s Competition Bureau

LSIPR